A Nationwide Epidemiological, Educational Support Program for Improving Treatment Adherence in Patients With HBV
NCT01991262 · Status: WITHDRAWN · Type: OBSERVATIONAL
Last updated 2018-07-24
Summary
Protocol Title: A Nationwide Epidemiological, Non-Interventional Study Evaluating an Educational Support Program for Improving Treatment Adherence in Patients with Hepatitis B Viral Infection
Objective(s): The primary objectives of the study are to assess:
* HBV treatment adherence rate in patients enrolled in the Support Program
* Adherence rates at 6m, 12m.
The secondary objectives are to assess:
* Adverse events rate and profile.
* Actual treatment duration and dose taken vs. prescribed.
* The impact of SMS reminders.
Study Design: Eligible patients will be randomized into one of four groups: Group 1 shall receive both a weekly phone call from a supporter and a daily SMS reminder. Group 2 will receive a weekly phone call only. Group 3 will receive a daily SMS reminder only and group 4 (Control) shall receive no support.
Study Population: Adult newly diagnosed with Hep B patients, eligible to begin treatment with first line therapy.
Data Collection Methods:
1. Supporter's documentations of patient's self assessment.
2. Drugs dispense data from pharmacies
3. Pills count.
Conditions
- HBV Treatment Adherence by Support Program
Sponsors & Collaborators
-
Carmel Medical Center
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 90 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-04-30
- Primary Completion
- 2016-05-31
- Completion
- 2016-05-31
More Related Trials
-
DEcentralize Testing, Education, and Linkage to Care by Using Electronic Best Practice Advisory for Hepatitis B (DETECT-B)
NCT06403657 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Modified Dose and Schedule of Recombinant Hepatitis B Vaccination in HIV-infected Adult Subjects
NCT01289106 ·Status: UNKNOWN ·Phase: PHASE3
-
Study of the Efficacy and Safety of HS-10234 in Patients With Chronic Hepatitis B Virus Infection
NCT03903796 ·Status: COMPLETED ·Phase: PHASE3
-
Towards a Functional Cure for HBV - The COMMIT Cohort Study
NCT03645044 ·Status: ACTIVE_NOT_RECRUITING
-
Effort to Narrow the Gap Between in Accordance With Guidelines and Consent to Treat CHB Population in East of China
NCT04980664 ·Status: UNKNOWN ·Phase: NA
-
Safety and Antiviral Study of ACH-126, 443 (Beta-L-Fd4C) in the Treatment of Adults With Chronic Hepatitis B Infection.
NCT00037622 ·Status: TERMINATED ·Phase: NA
-
An Observational Study of Patients With Chronic Hepatitis B (CHB) Infection
NCT03692897 ·Status: TERMINATED
-
A Study in Chronic Hepatitis B e-Antigen Negative Participants After Discontinuation of Nucleos(t)Ide Analog (NA) Treatment
NCT05550519 ·Status: WITHDRAWN ·Phase: EARLY_PHASE1
-
Continued Access Study of Adefovir Dipivoxil (ADV) for Patients w/Chronic HBV Infection.
NCT00158704 ·Status: TERMINATED ·Phase: NA
-
Liver Injury by Statins in Patients With History of Hepatitis B Virus Infection
NCT02808299 ·Status: UNKNOWN
-
Efficacy of Telbivudine in Blacks/African Americans and Hispanics/Latinos With Compensated Chronic Hepatitis B During 52 Weeks
NCT00862706 ·Status: WITHDRAWN ·Phase: PHASE4
-
Lamivudine and Adefovir to Treat Chronic Hepatitis B
NCT00023309 ·Status: COMPLETED ·Phase: PHASE2
-
Combination Entecavir and Peginterferon Therapy in HBeAg-Positive Immune-Tolerant Adults With Chronic Hepatitis B
NCT01369199 ·Status: TERMINATED ·Phase: PHASE3
-
Long-term Outcomes of Anti-viral Therapies in Patients With Chronic Viral Hepatitis B
NCT04896255 ·Status: RECRUITING
-
A Phase II Study of Hepalatide in Subjects With Chronic Hepatitis B
NCT04426968 ·Status: COMPLETED ·Phase: PHASE2
-
The Norwegian Nucleoside Analogue Stop Study
NCT03681132 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy Study of Prednisone Priming to Treat Asian Chronic Hepatitis B Patients
NCT00715715 ·Status: WITHDRAWN ·Phase: NA
-
A Clinical Study of 162 in Subjects With Chronic Hepatitis B Virus Infection
NCT06159062 ·Status: TERMINATED ·Phase: PHASE1
-
The Effect of an Electronic Medical Record (EMR) Alert on Hepatitis B Screening
NCT04240678 ·Status: COMPLETED ·Phase: NA
-
Dose Ranging Study of Pegylated Interferon Lambda in Patients With Hepatitis B and Positive for the Hepatitis B e Antigen
NCT01204762 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of HepaGam B® in Combination With Antiviral Treatment in Hepatitis B Liver Transplant Patients
NCT00722332 ·Status: COMPLETED ·Phase: PHASE4
-
Determinants of Virological Response After Discontinuation of Nucleoside Analogue Therapy in Hepatitis B Patients
NCT02581033 ·Status: UNKNOWN ·Phase: NA
-
A Study of TQ-A3334 Combined With Entecavir in the Treatment of Chronic Hepatitis B
NCT04180150 ·Status: UNKNOWN ·Phase: PHASE2
-
Clinical Efficacy and Safety of Tenofovir Disoproxil Fumarate and Entcavir in Treatment of Chronic Hepatitis B Patients in Upper Egypt
NCT05874440 ·Status: UNKNOWN
-
HepB-CpG Series for Healthcare Workers Who Are Hepatitis B Vaccine Nonresponders
NCT04456504 ·Status: COMPLETED ·Phase: PHASE4